Joel Moss
Overview
Explore the profile of Joel Moss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
336
Citations
7520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Worthy T, Jones A, Yang B, Ishiwata-Endo H, Gupta N, Moss J
Chest
. 2023 Sep;
165(2):303-306.
PMID: 37739031
No abstract available.
12.
Steagall W, Stylianou M, Pacheco-Rodriguez G, Yu Z, Moss J
ERJ Open Res
. 2023 Aug;
9(4).
PMID: 37589458
Lymphangioleiomyomatosis (LAM) is a multisystem disease affecting primarily women, characterised in the lung by proliferation of LAM cells, abnormal smooth muscle-like cells with dysfunctional tuberous sclerosis complex genes. This dysfunction...
13.
14.
Yang B, Moss J
Sci Adv
. 2023 May;
9(19):eadi1215.
PMID: 37163598
Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.
15.
Klonowska K, Giannikou K, Grevelink J, Boeszoermenyi B, Thorner A, Herbert Z, et al.
Am J Hum Genet
. 2023 May;
110(6):979-988.
PMID: 37141891
Tuberous sclerosis complex (TSC) is a neurogenetic disorder due to loss-of-function TSC1 or TSC2 variants, characterized by tumors affecting multiple organs, including skin, brain, heart, lung, and kidney. Mosaicism for...
16.
Pacheco-Rodriguez G, Steagall W, Glasgow C, Onishi R, Stylianou M, Kato J, et al.
Am J Respir Cell Mol Biol
. 2023 May;
68(5):591-594.
PMID: 37125895
No abstract available.
17.
18.
Treichel A, Boeszoermenyi B, Lee C, Moss J, Kwiatkowski D, Darling T
JID Innov
. 2023 Mar;
3(2):100180.
PMID: 36960317
Skin findings can be critical to determining whether a patient with lymphangioleiomyomatosis (LAM), a progressive pulmonary disease that predominantly affects adult women, has sporadic LAM or LAM in association with...
19.
Ishiwata-Endo H, Kato J, Oda H, Sun J, Yu Z, Liu C, et al.
bioRxiv
. 2023 Mar;
PMID: 36945646
Arginine-specific mono-ADP-ribosylation is a reversible post-translational modification; arginine-specific, cholera toxin-like mono-ADP-ribosyltransferases (ARTCs) transfer ADP-ribose from NAD to arginine, followed by cleavage of ADP-ribose-(arginine)protein bond by ADP-ribosylarginine hydrolase 1 (ARH1), generating...
20.
Yamashita S, Bu X, Ishiwata-Endo H, Kato J, Springer D, Noguchi A, et al.
bioRxiv
. 2023 Mar;
PMID: 36945462
Aims: Patients with ( ) deficiency exhibit stress-induced childhood-onset neurodegeneration with ataxia and seizures (CONDSIAS). ARH3 degrades protein-linked poly(ADP- ribose) (PAR) synthesized by poly(ADP-ribose)polymerase (PARP)-1 during oxidative stress, leading to...